A Clinical Trial of CAP-003 Gene Therapy in Adult Patients With GBA1 Associated Parkinson's Disease

Clinical trial NCT07011771 · WITHDRAWN

Trial details

NCT number: NCT07011771
Sponsor: Capsida Biotherapeutics, Inc.
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

GBA1 Parkinson Disease

Start date: 2025-08-18
Primary completion: 2026-06-17
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.